Vein illumination devices market seen reaching $1.06 billion by 2030

The vein illumination devices market is forecast to grow from $0.69 billion in 2026 to $1.06 billion by 2030, driven by demand for non-invasive vein visualization, outpatient use, and emergency care. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Vein illumination devices help clinicians find veins faster and more accurately for venipuncture, IV access and blood draws. - The technology is gaining traction as healthcare providers look for less invasive tools that can improve patient comfort and reduce needle-stick injuries. - The market outlook points to sustained demand across hospitals, outpatient settings, homecare and emergency services.

What happened: - The Business Research Company projected the global vein illumination devices market will rise from $0.61 billion in 2025 to $0.69 billion in 2026. - The report forecasts the market will reach $1.06 billion by 2030, implying an 11.2% CAGR over the forecast period. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - More information

The details: - Vein illumination devices are also called vein finders or vein locators. - The devices use near-infrared light, transillumination and ultrasound to make veins more visible beneath the skin. - The report cites growth drivers including more intravenous procedures, hospital and clinic expansion, wider use of handheld medical devices and stronger focus on patient comfort. - The forecast also reflects demand for non-invasive vein visualization, portable imaging features, and tools that improve first-attempt success rates. - Emerging trends include broader use in emergency and pediatric care and more portable near-infrared vein visualization tools. - The market’s recent growth was linked to more frequent IV procedures, broader access to care infrastructure and higher use of basic transillumination tools. - The report’s new 2026 additions include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspots infographics and updated graphics and tables. - Download a free sample of the report

Between the lines: - The biggest demand signal is not just device adoption, but the broader shift toward procedures that are quicker, safer and easier on patients. - Rising venous thromboembolism risk and more chronic disease management create more situations where reliable venous access matters. - The market is also benefiting from clinical workflows that favor portable tools over larger, more complex imaging systems. - The report cites NHS data showing about 90% of adult inpatients, or roughly 3.1 million out of 3.5 million admissions, were assessed for VTE risk in the second quarter of 2024–25. - The World Health Organization said chronic diseases caused nearly 74% of global deaths in 2023 and could reach 86% by 2048. - The American Society of Plastic Surgeons reported a 7% increase in minimally invasive procedures in 2023, outpacing traditional surgery growth by 2%.

What's next: - Growth is expected to continue as more providers adopt vein visualization tools in outpatient and homecare settings. - Emergency medical services and pediatric care are likely to be important adoption areas. - Product development will likely stay centered on portability, imaging accuracy and higher first-attempt success rates. - View the full market report

The bottom line: - Vein illumination devices are moving from a niche assistive tool to a broader clinical workflow product, and the market forecast suggests that shift will continue through 2030.